CA2426540A1 - Evaluation du niveau d'expression leucocytaire - Google Patents

Evaluation du niveau d'expression leucocytaire Download PDF

Info

Publication number
CA2426540A1
CA2426540A1 CA002426540A CA2426540A CA2426540A1 CA 2426540 A1 CA2426540 A1 CA 2426540A1 CA 002426540 A CA002426540 A CA 002426540A CA 2426540 A CA2426540 A CA 2426540A CA 2426540 A1 CA2426540 A1 CA 2426540A1
Authority
CA
Canada
Prior art keywords
expression
seq
disease
gene
array
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002426540A
Other languages
English (en)
Inventor
Jay Wohlgemuth
Kirk Fry
George Matcuk
Peter Altman
James Prentice
Julie Phillips
Ngoc Ly
Robert Woodward
Thomas Quertermous
Frances Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CareDx Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2426540A1 publication Critical patent/CA2426540A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

L'invention concerne l'évaluation du niveau d'expression génique d'un leucocyte utilisé pour identifier des oligonucléotides à partir de bibliothèques candidates d'expression génique. Ces bibliothèques d'expression sont généralement immobilisées sur une matrice. L'invention concerne également un oligonucléotide de diagnostic réglé de façon à analyser des maladies associées à un leucocyte.
CA002426540A 2000-10-20 2001-10-22 Evaluation du niveau d'expression leucocytaire Abandoned CA2426540A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24199400P 2000-10-20 2000-10-20
US60/241,994 2000-10-20
US29676401P 2001-06-08 2001-06-08
US60/296,764 2001-06-08
PCT/US2001/047856 WO2002057414A2 (fr) 2000-10-20 2001-10-22 Evaluation du niveau d'expression leucocytaire

Publications (1)

Publication Number Publication Date
CA2426540A1 true CA2426540A1 (fr) 2002-07-25

Family

ID=26934753

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002426540A Abandoned CA2426540A1 (fr) 2000-10-20 2001-10-22 Evaluation du niveau d'expression leucocytaire

Country Status (7)

Country Link
US (1) US20070037144A1 (fr)
EP (1) EP1334113A4 (fr)
CA (1) CA2426540A1 (fr)
IL (1) IL155450A0 (fr)
NZ (1) NZ525336A (fr)
WO (1) WO2002057414A2 (fr)
ZA (1) ZA200303132B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112813136A (zh) * 2021-03-17 2021-05-18 桂林优利特医疗电子有限公司 一种需氧菌性阴道炎检测试纸及其制备方法

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030229216A1 (en) 1998-10-13 2003-12-11 Ruoping Chen Constitutively activated human G protein coupled receptors
US7473528B2 (en) 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7026121B1 (en) * 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7125663B2 (en) 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
CA2790034A1 (fr) 2001-06-21 2003-01-03 Isis Pharmaceuticals, Inc. Modulation anti-sens de l'expression de la superoxyde dismutase 1 soluble
DE60220621T2 (de) 2001-11-09 2008-03-06 Proteologics, Inc. Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
JP2005517157A (ja) * 2002-01-18 2005-06-09 シンジェンタ・パティシペーションズ・アクチェンゲゼルシャフト 遺伝子発現レベル検出のためのプローブ補正
US20090149335A1 (en) * 2002-02-22 2009-06-11 Biolife Solutions Inc. Method and use of microarray technology and proteogenomic analysis to predict efficacy of human and xenographic cell, tissue and organ transplant
US20030232396A1 (en) * 2002-02-22 2003-12-18 Biolife Solutions, Inc. Method and use of protein microarray technology and proteomic analysis to determine efficacy of human and xenographic cell, tissue and organ transplant
US20040110157A1 (en) * 2002-12-10 2004-06-10 Isis Pharmaceuticals Inc. Modulation of acetyl-CoA acetyltransferase 2 expression
US7118865B2 (en) 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
AU2002343918A1 (en) * 2002-08-30 2004-04-08 Bml, Inc. Method of detecting genes specifying allergy predisposition
EP2272958A1 (fr) 2002-09-26 2011-01-12 ISIS Pharmaceuticals, Inc. Modulation de l'expression de la boîte Forkhead O1A
PL400309A1 (pl) 2002-12-23 2013-10-14 Immunex Corporation Kwasy nukleinowe, proteiny oraz przeciwciala BTL-II
US7223393B2 (en) 2003-02-07 2007-05-29 Pdl Biopharma, Inc Amphiregulin antibodies and their use to treat cancer and psoriasis
US7625723B2 (en) 2003-04-16 2009-12-01 Arkray, Inc. Method of detecting or quantitatively determining mitochondrial DNA 3243 variation, and kit therefor
US20060263813A1 (en) * 2005-05-11 2006-11-23 Expression Diagnostics, Inc. Methods of monitoring functional status of transplants using gene panels
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20070248978A1 (en) * 2006-04-07 2007-10-25 Expression Diagnostics, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
WO2005014795A2 (fr) 2003-08-08 2005-02-17 Genenews Inc. Biomarqueurs d'osteoarthrite et leurs utilisations
WO2005026314A2 (fr) * 2003-09-10 2005-03-24 Japan Science And Technology Agency Groupe de genes exprimes de facon differentielle dans des cellules de sang peripherique ainsi que procede de diagnostic et procede d'analyse mettant en oeuvre ce groupe
US20050153352A1 (en) * 2004-01-09 2005-07-14 Stanley Chang Cancer specific gene MG20
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7332597B2 (en) 2004-06-28 2008-02-19 University Of Kentucky Research Foundation Primers and probe to identify mycobacterium tuberculosis complex
WO2006007664A1 (fr) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents et methodes de diagnostic de l'osteoarthrite
US8080373B2 (en) * 2004-08-03 2011-12-20 Bauer Jr A Robert Method for the early detection of pancreatic cancer and other gastrointestinal disease conditions
US20080280282A1 (en) * 2004-08-03 2008-11-13 Bauer Jr A Robert Method for early detection of various cancers and gastrointestinal disease and monitoring of transplanted organs
US7820382B2 (en) * 2004-08-03 2010-10-26 Bauer A Robert Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation
US20130040840A1 (en) * 2004-09-02 2013-02-14 Bioarray Solutions, Ltd. Nucleic acid amplification with integrated multiplex detection
US7645575B2 (en) * 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
US7571055B2 (en) 2004-10-13 2009-08-04 Regents Of The University Of Minnesota Systemic lupus erythematosus
WO2006113678A2 (fr) * 2005-04-15 2006-10-26 Oncomethylome Sciences, Inc. Marqueurs de methylation pour le diagnostic et le traitement de cancers
US20070037186A1 (en) 2005-05-20 2007-02-15 Yuqiu Jiang Thyroid fine needle aspiration molecular assay
US20070173698A1 (en) * 2005-08-19 2007-07-26 Paul Kivela Fail-safe risk management system and methods
US20080026386A1 (en) 2006-03-31 2008-01-31 Behrens Timothy W Irf-5 haplotypes in systemic lupus erythematosus
TW200811111A (en) * 2006-04-20 2008-03-01 Glaxo Group Ltd Novel compounds
US20080057503A1 (en) 2006-04-24 2008-03-06 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
ATE539170T1 (de) 2006-04-27 2012-01-15 Univ Montreal Abschätzung und verringerung des risikos von graft-versus-host-reaktion
EP1872787A1 (fr) * 2006-06-27 2008-01-02 Gentium S.p.A. Utilisation de defibrotide pour l'inhibition de l'heparanase
US7993832B2 (en) * 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
WO2008140484A2 (fr) * 2006-11-09 2008-11-20 Xdx, Inc. Procédés pour diagnostiquer et surveiller l'état d'un lupus érythémateux systémique
AU2008254582A1 (en) * 2007-05-21 2008-11-27 Genentech, Inc. Methods and compositions for identifying and treating lupus
US7550300B1 (en) * 2007-11-29 2009-06-23 Capgen Sciences, Inc. Prediction of bare metal stent restenosis
EP2103689A1 (fr) * 2008-03-19 2009-09-23 Gentium S.p.A. Oligonucléotides phosphodiesters synthétiques et leurs utilisations thérapeutiques
EP2313531A1 (fr) * 2008-06-25 2011-04-27 Source Precision Medicine, Inc. Établissement de profil d expression génique pour l identification, le suivi, et le traitement de l arthrose
WO2010092417A1 (fr) * 2009-02-11 2010-08-19 Cgc Centro De Genetica Clinica, Sa Panels de diagnostic de multiples maladies génétiques par un test unique utilisant une technologie de microréseau
US9301975B2 (en) 2009-05-01 2016-04-05 Biocardia, Inc. Method of preparing autologous cells and method of use for therapy
CA2777055C (fr) 2009-10-07 2021-04-06 Genentech, Inc. Procedes pour traiter, diagnostiquer et surveiller un lupus
EP2637672B1 (fr) 2010-11-12 2018-08-22 Gentium S.r.l. Défibrotide pour une utilisation dans la prophylaxie et/ou le traitement de la maladie du greffon contre l'hôte (mgch)
WO2012170037A1 (fr) 2011-06-10 2012-12-13 Hitachi Chemical Co., Ltd. Dispositifs de capture de vésicule et leurs procédés d'utilisation
US9589099B2 (en) 2011-07-21 2017-03-07 The Chinese University Of Hong Kong Determination of gene expression levels of a cell type
AR091069A1 (es) 2012-05-18 2014-12-30 Amgen Inc Proteinas de union a antigeno dirigidas contra el receptor st2
CA2874960C (fr) 2012-06-22 2021-05-18 Gentium S.P.A. Procede a base d'euglobuline pour la determination de l'activite biologique de defibrotide
US9804149B2 (en) 2012-10-10 2017-10-31 Bio-Rad Laboratories, Inc. Patient-based results display
JP6297676B2 (ja) 2013-05-06 2018-03-20 日立化成株式会社 標的分子を捕捉するためのデバイス及び方法
JP2016540496A (ja) * 2013-10-02 2016-12-28 日立化成株式会社 移植後の肝臓の状態の評価、並びに、特異的な治療法の決定、及び適用のための方法
SG10201906520RA (en) 2014-04-01 2019-09-27 Biogen Ma Inc Compositions for modulating sod-1 expression
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
EP3218521B1 (fr) 2014-11-12 2019-12-25 Hitachi Chemical Co., Ltd. Procédé permettant de diagnostiquer une lésion touchant un organe
EP3026122A1 (fr) 2014-11-27 2016-06-01 Gentium S.p.A. Procédé à base cellulaire pour déterminer la puissance de défibrotide
US11037070B2 (en) * 2015-04-29 2021-06-15 Siemens Healthcare Gmbh Diagnostic test planning using machine learning techniques
WO2017040520A1 (fr) 2015-08-31 2017-03-09 Hitachi Chemical Co., Ltd. Méthodes moléculaires pour évaluer une maladie urothéliale
CN106706925B (zh) * 2016-12-12 2018-08-10 北京大学人民医院 一种筛查或辅助诊断炎症性肠病的方法及适用于该方法的试剂盒
CN116536279B (zh) * 2022-01-25 2023-11-14 杭州馨海酶源生物科技有限公司 一种基因工程菌及在制备去氢表雄酮上的应用

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212071A (en) * 1988-04-01 1993-05-18 The Johns Hopkins University Nucleic acids encoding a human C3b/C4b receptor (CR1)
US4190535A (en) * 1978-02-27 1980-02-26 Corning Glass Works Means for separating lymphocytes and monocytes from anticoagulated blood
US4762780A (en) * 1984-04-17 1988-08-09 The Regents Of The University Of California Method and composition for screening and diagnosing "HCMV"
US4582789A (en) * 1984-03-21 1986-04-15 Cetus Corporation Process for labeling nucleic acids using psoralen derivatives
US4818418A (en) * 1984-09-24 1989-04-04 Becton Dickinson And Company Blood partitioning method
US4751001A (en) * 1984-09-24 1988-06-14 Becton Dickinson And Company Blood partitioning apparatus
US6197563B1 (en) * 1985-03-28 2001-03-06 Roche Molecular Systems, Inc. Kits for amplifying and detecting nucleic acid sequences
US6040166A (en) * 1985-03-28 2000-03-21 Roche Molecular Systems, Inc. Kits for amplifying and detecting nucleic acid sequences, including a probe
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5604099A (en) * 1986-03-13 1997-02-18 Hoffmann-La Roche Inc. Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US5407800A (en) * 1986-08-22 1995-04-18 Hoffmann-La Roche Inc. Reverse transcription with Thermus thermophilus polymerase
US5310652A (en) * 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
US5795762A (en) * 1986-08-22 1998-08-18 Roche Molecular Systems, Inc. 5' to 3' exonuclease mutations of thermostable DNA polymerases
US5405774A (en) * 1986-08-22 1995-04-11 Hoffmann-La Roche Inc. DNA encoding a mutated thermostable nucleic acid polymerase enzyme from thermus species sps17
US5618711A (en) * 1986-08-22 1997-04-08 Hoffmann-La Roche Inc. Recombinant expression vectors and purification methods for Thermus thermophilus DNA polymerase
US5322770A (en) * 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5374553A (en) * 1986-08-22 1994-12-20 Hoffmann-La Roche Inc. DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima
US5079352A (en) * 1986-08-22 1992-01-07 Cetus Corporation Purified thermostable enzyme
CA1297431C (fr) * 1987-04-24 1992-03-17 F. Hoffmann-La Roche Ag Procede pour l'isolation d'acides nucleiques
US4908318A (en) * 1987-09-04 1990-03-13 Integrated Genetics, Inc. Nucleic acid extraction methods
US4843155A (en) * 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5120525A (en) * 1988-03-29 1992-06-09 Immunomedics, Inc. Radiolabeled antibody cytotoxic therapy of cancer
US5693760A (en) * 1988-04-14 1997-12-02 Incyte Pharmaceuticals, Inc. Method of causing selective immunosuppression using HL-60 related lectins
US5091310A (en) * 1988-09-23 1992-02-25 Cetus Corporation Structure-independent dna amplification by the polymerase chain reaction
US5142033A (en) * 1988-09-23 1992-08-25 Hoffmann-La Roche Inc. Structure-independent DNA amplification by the polymerase chain reaction
US5389512A (en) * 1988-10-07 1995-02-14 Hoffman-La Roche Inc. Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5219727A (en) * 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
US5340720A (en) * 1989-11-29 1994-08-23 University Of Kansas Methods of diagnosing and monitoring rheumatic diseases
US5215882A (en) * 1989-11-30 1993-06-01 Ortho Diagnostic Systems, Inc. Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays
CA2033692A1 (fr) * 1990-01-25 1991-07-26 Wilhelm Bannwarth Systemes de transfert d'energie
DK0515506T3 (da) * 1990-02-16 2000-05-08 Hoffmann La Roche Fremgangsmåde til påvisning af carcinogene humane papillomavirus
US5344755A (en) * 1990-04-21 1994-09-06 The United States Of America As Represented By The Department Of Health And Human Services Method for detecting immune system dysfunction in asymptomatic, HIV-scropositive individuals
US5130423A (en) * 1990-07-13 1992-07-14 Microprobe Corporation Non-corrosive compositions and methods useful for the extraction of nucleic acids
ATE176002T1 (de) * 1990-07-24 1999-02-15 Hoffmann La Roche Verringerung von nicht spezifischer amplifikation während einer (in vitro) nukleinsäure amplifikation unter verwendung von modifizierten nukleinsäure basen
US5210015A (en) * 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
DE4034036C2 (de) * 1990-10-26 1994-03-03 Diagen Inst Molekularbio Vorrichtung und Verfahren zur Isolierung von Nukleinsäuren aus Zellsuspensionen
ES2078733T3 (es) * 1991-01-22 1995-12-16 Akzo Nobel Nv Metodo para la deteccion de anticuerpos anti-arn.
WO1992017198A1 (fr) * 1991-03-28 1992-10-15 The Regents Of The University Of Minnesota Adn et sequence d'acide amine specifiques de cellules tueuses k naturelles
US5994056A (en) * 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
ES2091976T3 (es) * 1991-06-20 1996-11-16 Hoffmann La Roche Metodos perfeccionados para la amplificacion del acido nucleico.
US5445940A (en) * 1991-08-28 1995-08-29 Brigham & Women's Hospital Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
US5487970A (en) * 1992-06-17 1996-01-30 Arch Development Corp. Compositions and methods for detecting gene rearrangements and translocations
GB2268935B (en) * 1992-06-24 1996-10-23 Nat Heart & Lung Inst Diagnosis of rejection of transplanted organs
ES2194843T3 (es) * 1992-09-11 2003-12-01 Hoffmann La Roche Deteccion de acidos nucleicos en sangre.
US6403304B1 (en) * 1993-04-06 2002-06-11 Forsyth Dental Infirmary For Children Human osteoclast-specific and -related DNA sequences
US5491086A (en) * 1993-05-14 1996-02-13 Hoffmann-La Roche Inc. Purified thermostable nucleic acid polymerase and DNA coding sequences from pyrodictium species
US6045996A (en) * 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
EP0690673A4 (fr) * 1993-12-14 1996-05-29 Univ Pittsburgh Traitement systemique par genes des affections des tissus conjonctifs
DK145393D0 (da) * 1993-12-23 1993-12-23 Stig Haunsoe Proteinmarkoerer til forudsigelse af akut allotransplantatafstoedning
US5512462A (en) * 1994-02-25 1996-04-30 Hoffmann-La Roche Inc. Methods and reagents for the polymerase chain reaction amplification of long DNA sequences
US6190872B1 (en) * 1994-05-06 2001-02-20 Gus J. Slotman Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method
US5658744A (en) * 1994-07-22 1997-08-19 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying patients having an altered immune status
US5491063A (en) * 1994-09-01 1996-02-13 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US5968770A (en) * 1995-02-10 1999-10-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
DE69621507T2 (de) * 1995-03-28 2003-01-09 Japan Science & Tech Corp Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen
US6251597B1 (en) * 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US5635365A (en) * 1995-08-07 1997-06-03 Emory University Noninvasive diagnosis for allograft rejection
US5773258A (en) * 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
US6099823A (en) * 1996-02-16 2000-08-08 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease
CA2247246A1 (fr) * 1996-02-16 1997-08-21 Millennium Pharmaceuticals, Inc. Compositions et procedes de traitement et de diagnostic des maladies cardio-vasculaires
CZ293215B6 (cs) * 1996-08-06 2004-03-17 F. Hoffmann-La Roche Ag Rekombinantní tepelně stálá DNA polymeráza, způsob její přípravy a prostředek, který ji obsahuje
US6060240A (en) * 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US6090556A (en) * 1997-04-07 2000-07-18 Japan Science & Technology Corporation Method for quantitatively determining the expression of a gene
US6010853A (en) * 1997-05-29 2000-01-04 Dana-Farber Cancer Institute Siva genes, novel genes involved in CD27-mediated apoptosis
US6228628B1 (en) * 1997-07-09 2001-05-08 Roche Molecular Systems Mutant chimeric DNA polymerase
AU9200398A (en) * 1997-08-22 1999-03-16 Yale University A process to study changes in gene expression in granulocytic cells
US6187534B1 (en) * 1997-09-24 2001-02-13 Cornell Research Foundation, Inc. Methods of evaluating transplant rejection
EP1027456B1 (fr) * 1997-10-31 2005-03-16 Affymetrix, Inc. (a Delaware Corporation) Profils d'expression dans des organes d'adultes et de foetus
US6248528B1 (en) * 1998-04-06 2001-06-19 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
US6048695A (en) * 1998-05-04 2000-04-11 Baylor College Of Medicine Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
AU759785C (en) * 1998-05-05 2003-12-04 Gene Logic, Inc. A process to study changes in gene expression in T lymphocytes
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
US6410319B1 (en) * 1998-10-20 2002-06-25 City Of Hope CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
US6248527B1 (en) * 1998-10-21 2001-06-19 Millennium Pharmaceuticals, Inc. Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E
US6194158B1 (en) * 1998-11-12 2001-02-27 Nyxis Neurotherapies, Inc. Diagnostic assay for cancer
US6177254B1 (en) * 1998-12-15 2001-01-23 Jerome Bernard Rattner Nucleolus autoantigenic marker for systemic lupus erthyematosus
US6087112A (en) * 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US6242185B1 (en) * 1999-04-01 2001-06-05 Incyte Genomics, Inc. Purified nucleic acid encoding transcription factor regulatory protein
US6245526B1 (en) * 1999-05-26 2001-06-12 Incyte Pharmaceuticals, Inc. Lipid metabolism transcription factor
US6168933B1 (en) * 1999-06-08 2001-01-02 Incyte Pharmaceuticals, Inc. Phospholipid transfer protein
US6245527B1 (en) * 1999-06-30 2001-06-12 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding glycoprotein VI and recombinant uses thereof
US6225093B1 (en) * 1999-09-07 2001-05-01 Decode Genetics Ehf. Detection of C4A deletion by long range PCR
US20020090673A1 (en) * 2000-01-31 2002-07-11 Rosen Craig A. Nucleic acids, proteins, and antibodies

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112813136A (zh) * 2021-03-17 2021-05-18 桂林优利特医疗电子有限公司 一种需氧菌性阴道炎检测试纸及其制备方法

Also Published As

Publication number Publication date
EP1334113A2 (fr) 2003-08-13
EP1334113A4 (fr) 2007-08-08
WO2002057414A9 (fr) 2003-09-12
US20070037144A1 (en) 2007-02-15
IL155450A0 (en) 2003-11-23
NZ525336A (en) 2006-03-31
WO2002057414A2 (fr) 2002-07-25
ZA200303132B (en) 2004-09-23
WO2002057414A3 (fr) 2002-09-26

Similar Documents

Publication Publication Date Title
CA2426540A1 (fr) Evaluation du niveau d'expression leucocytaire
US7235358B2 (en) Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) Methods and compositions for diagnosing and monitoring transplant rejection
US20040009479A1 (en) Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7879556B2 (en) Methods and compositions for diagnosing and monitoring transplant rejection
AU2002248176A1 (en) Leukocyte expression profiling

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130228